Montag & Caldwell, LLC
- SEC CIK
- 0000067698
- Latest filing
- Aug 15, 2025
EW holding history
Edwards Lifesciences Corp in every 13F filed by Montag & Caldwell, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2025 holdings
- Shares (Q2 2025)
- 90,353
- Value
- $7.07M
- % of portfolio
- 1.5%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 90,353 | $7.07M | 1.5% | +1,940+2.2% | Added | Holders |
| Q1 2025 | 88,413 | $6.41M | 1.5% | −3,446−3.8% | Reduced | Holders |
| Q4 2024 | 91,859 | $6.80M | 1.5% | −9,332−9.2% | Reduced | Holders |
| Q3 2024 | 101,191 | $6.68M | 1.4% | −83,359−45.2% | Reduced | Holders |
| Q2 2024 | 184,550 | $17.0M | 3.4% | −46,850−20.2% | Reduced | Holders |
| Q1 2024 | 231,400 | $22.1M | 3.8% | +14,333+6.6% | Added | Holders |
| Q4 2023 | 217,067 | $16.6M | 2.9% | −160,811−42.6% | Reduced | Holders |
| Q3 2023 | 377,878 | $26.2M | 3.4% | +72,686+23.8% | Added | Holders |
| Q2 2023 | 305,192 | $28.8M | 3.5% | −3,381−1.1% | Reduced | Holders |
| Q1 2023 | 308,573 | $25.5M | 3.4% | −641−0.2% | Reduced | Holders |
| Q4 2022 | 309,214 | $23.1M | 3.3% | +118,346+62.0% | Added | Holders |
| Q3 2022 | 190,868 | $15.8M | 2.3% | +95,740+100.6% | Added | Holders |
| Q2 2022 | 95,128 | $9.05M | 1.3% | −91,986−49.2% | Reduced | Holders |
| Q1 2022 | 187,114 | $22.0M | 2.5% | −2,000−1.1% | Reduced | Holders |
| Q4 2021 | 189,114 | $24.5M | 2.4% | −22,880−10.8% | Reduced | Holders |
| Q3 2021 | 211,994 | $24.0M | 2.2% | −6,091−2.8% | Reduced | Holders |
| Q2 2021 | 218,085 | $22.6M | 2.0% | −12,464−5.4% | Reduced | Holders |
| Q1 2021 | 230,549 | $19.3M | 1.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.